These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33179243)

  • 1. [Prenatal diagnosis of Rasopathies in Ras/MAPK signaling pathway].
    Zhang J; Zeng Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Nov; 37(11):1291-1295. PubMed ID: 33179243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in RASopathies.
    Aoki Y; Niihori T; Inoue S; Matsubara Y
    J Hum Genet; 2016 Jan; 61(1):33-9. PubMed ID: 26446362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA Genetic Variants Alter Their Secondary Structure and Expression in Patients With RASopathies Syndromes.
    de Carvalho JB; de Morais GL; Vieira TCDS; Rabelo NC; Llerena JC; Gonzalez SMC; de Vasconcelos ATR
    Front Genet; 2019; 10():1144. PubMed ID: 31798637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Genetics of Noonan Syndrome and RASopathies.
    Liao J; Mehta L
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
    Zenker M
    Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
    Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D
    Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
    Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASopathies: Evolving Concepts in Pathogenetics, Clinical Features, and Management.
    Padhiyar J; Mahajan R; Panda M
    Indian Dermatol Online J; 2024; 15(3):392-404. PubMed ID: 38845651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on the treatment of RASopathies].
    Duat-Rodriguez A; Hernandez-Martin A
    Rev Neurol; 2017 May; 64(s03):S13-S17. PubMed ID: 28524213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rasopathies: developmental disorders that predispose to cancer and skin manifestations].
    Hernández-Martín A; Torrelo A
    Actas Dermosifiliogr; 2011; 102(6):402-16. PubMed ID: 21536246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASopathies: unraveling mechanisms with animal models.
    Jindal GA; Goyal Y; Burdine RD; Rauen KA; Shvartsman SY
    Dis Model Mech; 2015 Aug; 8(8):769-82. PubMed ID: 26203125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
    Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
    Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number variants including RAS pathway genes-How much RASopathy is in the phenotype?
    Lissewski C; Kant SG; Stark Z; Schanze I; Zenker M
    Am J Med Genet A; 2015 Nov; 167A(11):2685-90. PubMed ID: 25974318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
    Bezniakow N; Gos M; Obersztyn E
    Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
    Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
    Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the MAPK pathway (RASopathies) and partial growth hormone insensitivity.
    Malaquias AC; Jorge AAL
    Mol Cell Endocrinol; 2021 Jan; 519():111040. PubMed ID: 33011209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13q31.1 microdeletion: A prenatal case report with macrocephaly and macroglossia.
    Poreau B; Lin S; Bosson C; Dieterich K; Satre V; Devillard F; Guigue V; Ronin C; Brouillet S; Barbier C; Jouk PS; Coutton C
    Eur J Med Genet; 2015 Oct; 58(10):526-30. PubMed ID: 26365529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RASopathies and hematologic abnormalities].
    Aoki Y
    Rinsho Ketsueki; 2015 Oct; 56(10):2240-7. PubMed ID: 26458465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo severity ranking of Ras pathway mutations associated with developmental disorders.
    Jindal GA; Goyal Y; Yamaya K; Futran AS; Kountouridis I; Balgobin CA; Schüpbach T; Burdine RD; Shvartsman SY
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):510-515. PubMed ID: 28049852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.